Latest news with #StephanieStrong
Associated Press
06-05-2025
- Health
- Associated Press
Boulder Care Reaches Agreement with Cone Health to Expand Access to Telehealth Addiction Treatment in North Carolina
The collaboration will connect more North Carolinians with Boulder's compassionate and evidence-based recovery support services. 'It's a privilege to partner with Cone Health to extend high-quality healthcare to our communities: ensuring care continuity, quality, and flexibility for patients to access care anywhere they are.' — Stephanie Strong, CEO and Founder of Boulder Care GREENSBORO, NC, UNITED STATES, May 6, 2025 / / -- Boulder Care, a leading provider of telehealth-based addiction treatment, is proud to announce a new agreement with Cone Health to expand access to critical care for individuals living with opioid and alcohol use disorders in North Carolina. The collaboration will bring Boulder's telehealth model of care—grounded in respect, compassion, and long-term support—to individuals in Greensboro and beyond, ensuring that people living with substance use disorders have access to the care they need, when they need it. Stephanie Strong, founder and CEO of Boulder Care and native North Carolinian, commented on the news, 'Boulder's low-barrier care model helps patients access immediate help for their addiction, and remain in treatment long-term without taking time away from their work or families. It's a privilege to partner with Cone Health to extend high-quality healthcare to our communities: ensuring care continuity, quality, and flexibility for patients to access care anywhere they are.' The new agreement will allow Cone Health's Behavioral Health Services to refer individuals to Boulder Care, which offers a comprehensive suite of services, including medication-assisted treatment (MAT) and evidence-based recovery support services. With Boulder's telehealth capabilities, patients can access these services from the comfort and privacy of their own homes, using smartphones, tablets, or computers. 'When a person struggling with addiction makes the decision to get help, we want to provide that help as soon as possible,' says Dave Jenkins, the executive director of Cone Health Behavioral Health Services, 'Having treatment available through telehealth makes it even easier to provide the care and support we want to provide our patients.' The collaboration will focus on individuals aged 18 and older living with opioid use disorder (OUD) or alcohol use disorder (AUD) who are seeking telehealth addiction treatment. Patients will receive customized care plans tailored to their specific recovery goals, with a focus on long-term wellness and harm reduction. Boulder's commitment to evidence-based, longitudinal treatment aims to reduce the risk of overdose and other adverse health outcomes associated with substance use. The collaboration also emphasizes the importance of addressing social determinants of health and working closely with community organizations to ensure a holistic approach to addiction recovery. If you or someone you know is interested in learning more about Boulder's treatment options, please download the Boulder Care app on your mobile phone or visit to enroll. You can also enroll by telephone at 866-901-4860. Boulder accepts Medicaid, Medicare, and most insurance plans. About Boulder Care Boulder is a leader in high-quality addiction medicine, providing evidence-based treatment for opioid and alcohol use over telehealth. Dedicated care teams collaborate to provide low-barrier access to medication-based treatment and emphasize long-term support as patients work toward unique recovery goals. Boulder partners with health plans and community organizations to offer affordable treatment to patients across the U.S. Learn more about Boulder's mission to improve the lives of people with substance use disorders at or contact us at [email protected]. Katie ONeill Boulder Care email us here Visit us on social media: LinkedIn Instagram X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
21-03-2025
- Health
- Yahoo
Cutting Medicaid could worsen overdose deaths — and erase recent progress in treating addiction
When Kim, a grandmother in recovery, moved to North Carolina to be closer to her son in 2018, she initially had difficulties filling her buprenorphine (Suboxone) prescription because her provider could no longer prescribe her medication across state lines. 'Using Suboxone has greatly helped me not only be free of drugs and alcohol for the whole time being here, but it's my livelihood,' Kim, who is using her first name only for privacy reasons, told Salon in a phone interview. 'I can't function without it — and I've tried.' In the 20 years that Kim has been using buprenorphine, there have been several times where changes in her life, like her move, or changes in policy have abruptly cut her off from her medication. She has been able to access treatment through Medicaid, the health insurance program for low-income Americans, uninterrupted for the past couple of years. But she worries that budget cuts being debated by Republicans could take that away. 'This saved my life… and it can save a lot more,' Kim said. 'I don't understand why you would try to take it from people.' Medications like buprenorphine and methadone are considered the gold standard for treating addiction, according to decades of research, because they can reduce deaths as well as improve social functionality. Increased access to these drugs is thought to be a major factor contributing to the first significant reduction in national overdose deaths to occur since 2018. Although 87,000 Americans still died from overdoses in 2024, a decline of 24% from the previous year, many are concerned this progress could be lost, especially if the federal government makes significant cuts to Medicaid. 'It's time to double down on all of the things that have been working, not reverse them,' said Stephanie Strong, co-founder and CEO of Boulder Care, a telehealth addiction treatment center. 'That's what I fear will happen if people lose their health benefits.' President Donald Trump has promised to cut between $1.5 and $2 trillion from the federal budget in the next decade. Although he has said he will not cut Medicaid, Senate Republicans have been debating whether to overhaul the program. Some are skeptical that the administration will cut Medicaid significantly, but an analysis performed by The Congressional Budget Office earlier this month found that it would be impossible to find enough cuts elsewhere that do not affect Medicaid in some way. Medicaid, the largest source of insurance for addiction treatment, has demonstrably saved lives and improved access for many people seeking addiction treatment. In one 2020 study, Medicaid expansions were associated with between 1,678 and 8,132 lives saved from an overdose between 2015 and 2017. Another 2021 study found admissions for addiction treatment were 36% in states that had expanded Medicaid four years after the expansion compared to ones that had not. 'Probably the single biggest policy-level change that has benefited addiction treatment has been guaranteeing Medicaid and Medicare coverage for medical treatment of addiction with methadone and buprenorphine,' Dr. Ryan Marino, an emergency medicine physician at Case Western Reserve University School of Medicine, told Salon. 'More people are certainly able to access evidence-based treatment, and lives have been saved.' Trump's stance on drug policy seems to largely be focused on the criminalization of drugs rather than treating the overdose crisis like a public health issue, which experts say is not as effective in stemming the overdose crisis. Trump has said that he issued high tariffs on Mexico, Canada and China because 'they've allowed fentanyl to come into our country at levels never seen before' and has even threatened war with drug cartels. But this week, the Trump administration also extended an emergency declaration to address the national opioid crisis, first declared in 2017, which allows for some expedited decisions to be made related to substance use disorder treatments. Still, if the Trump administration does cut Medicaid funding, regions in which its constituents live could be hardest hit by the decision. In West Virginia and Tennessee, for example, two states where Trump won the vote in the 2024 election, upwards of 20% of the population is on Medicaid. And these two states have some of the highest rates of per-capita overdose deaths in the country. Medicaid funding not only expands access to medication-assisted treatment like buprenorphine and methadone, but also funds things like group or individual therapy as well as programs that help people find employment and other aspects of recovery in certain states, said Dr. Elizabeth Stone, who researches health services and policy at Rutgers University. 'Recovery is an ongoing process and for people who are stabilized with medication for opioid-use disorder or are seeing their therapist regularly, losing insurance coverage can be a really high-risk time for harm,' Stone told Salon in a phone interview. 'Downstream, then you're also potentially having people even less likely to access care than they already are now.' If Medicaid access is reduced, Kim worries about the time it would take to switch over to another insurance, if she could even find one she could afford. 'That would be days or weeks from getting any kind of insurance, and if you are sick and going through withdrawals, you're not going to wait,' Kim said. 'You're going to go and do whatever you can to get to feeling better.' Policies that cut Medicaid might include taking away coverage from people who don't meet certain work requirements or limiting payments given to states, pushing the states to make the cuts. But cutting work requirements, for example, has been tried by some states without success. In Arkansas, a temporary program with these requirements led to the loss of coverage for thousands of people but did not increase employment. 'My perspective is that they're not actually effective in reducing the number of people who are eligible for Medicaid, they just create more hoops and ultimately, more costs and administrative waste,' Strong told Salon in a phone interview. '[We need to be] making sure the resources are going to the right places, and leveraging technology and telemedicine to offer care that's lower cost and more available in rural areas, rather than investing in building more facilities and more beds.' Nevertheless, whether potential cuts to Medicaid funding would in fact cut costs is unclear. Like with any medicine, reducing access to treatments used for addiction can make people seek care when they have more health care needs, which ends up costing more money. In one 2021 analysis, all forms of medication-assisted treatment (buprenorphine, methadone and naltrexone) were associated with up to $100,000 in lifetime cost savings per person compared to people who were not treated. Additionally, because the Centers for Medicare and Medicaid Services covers such a large portion of the population, the center can often negotiate drug prices to be lower, which affects the market and can benefit people on other insurances, Marino said. 'They're saying that they're saving us money by doing these cuts, but there are very few things that are as cost-effective as Medicare and Medicaid,' Marino said. 'Not only because of the kind of preventable health benefit and downstream economic benefits, but also because CMS can negotiate down the prices of drugs, and even people who are on private insurance then get benefits.' Some hospitals and treatment centers are also dependent on reimbursements from CMS, so even a small cut in Medicaid could affect their funding and lead to shutdowns, Marino said. 'That is going to impact not only people who are in addiction treatment,' Marino said. 'If the closest hospitals shut down and you now have to drive 30 minutes away when you're having a stroke or a heart attack or someone is overdosing, that is going to lead to a lot of additional problems.' These decisions are expected to be made in mid-2025, when Congress faces a deadline for passing Trump's agenda. For now, the close to 4.9 million people using Medicaid for addiction treatment will have to wait and see if they are impacted. 'We're trying to get ourselves better and we're trying to be drug-free,' Kim said. 'I would hope that the government could see that.'
